The Management of Gastrointestinal Cancers
Treatment of rectal cancer has improved greatly over recent decades. This session will review t the pivotal trials in the development of the current standard of therapy as well as new directions for more individualized therapy for rectal cancer. The use of radiotherapy in resectable, borderline resectable, and locally advanced pancreas cancer has been evolving with the results of recent phase II and III trials. Incorporation of SBRT in the armamentarium for pancreas and liver tumors is allowing for better integration of local therapy with systemic agents. Finally, the use of PET imaging is helping to direct therapy for esophageal cancers, we will review the ongoing approaches to better tailor therapy.
This program is designed to meet the interest of radiation oncologists and radiation oncology residents.
- Describe the emerging paradigms in treatment for rectal cancer
- Apply advances in treatment of pancreatic cancer and be familiar with ongoing Phase II and Phase III trials
- Identify the use of Stereotactic Body Radiation Therapy (SBRT) in oncologic treatment for liver and pancreas tumors
- Incorporate the use of molecular imaging in the treatment of esophageal cancer
Karyn Goodman, MD has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Journal CME Task Force and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.